Evidence map›Paper›PMID 42111180›Full record

ArticleiScience2026

Wasteosomes (corpora amylacea) of the human brain accumulate in CD44-positive astrocytes.

Marina Sartorio, Marta Riba, Carme Pelegrí, Jordi Vilaplana, James E Goldman

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marina SartorioSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain.
Marta RibaSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain.
Carme PelegríSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain.
Jordi VilaplanaSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain.
James E GoldmanDepartment of Pathology and Cell Biology, Columbia University, 630 West 168th Street, New York, NY 10032, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wasteosomes or corpora amylacea are polyglucosan inclusions that accumulate in the human central nervous system during aging and in several neurodegenerative diseases. They are formed in astrocytes, act as waste containers, and can be released into the cerebrospinal fluid. In the present study, we hypothesized that CD44-positive astrocytes are the cells that harbor these structures. Brain tissue samples from non-diseased and diseased cases were analyzed by immunohistochemistry and immunofluorescence. Across multiple brain regions, wasteosomes were exclusively found in areas where astrocytes were CD44-positive. Notably, GFAP-positive astrocytic filaments are observed between the wasteosomes and the CD44 membrane receptor, supporting that the wasteosome-containing astrocytes are CD44-positive. In addition, some wasteosomes observed in the subarachnoid space contained CD44 remnants adhered to their surface. These findings identify CD44-positive astrocytes as the principal cellular niche for wasteosomes. The possible roles of CD44 in wasteosome biogenesis and release are discussed, opening the way for future studies.

Indexed as

Biological sciencesClinical neuroscienceHealth sciencesMedicineNeurologyNeuroscience

Identifiers

PMID42111180
PMCPMC13157177

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.